Evidence map›Paper›PMID 41040357›Full record

ArticlebioRxiv : the preprint server for biology2025

Rare bioactive tau oligomers from Alzheimer brain support both templated misfolding and fibril formation.

Noé Quittot, Dhanush Sivasankaran, Dorothea Boeken, Yu Chen, Joshua E Chun, Anne Wiedmer, Victoria Derosla, Mariana B M S Martins, Forest A Brooks, Georg Meisl and 10 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Noé QuittotDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0003-1946-8677
Dhanush SivasankaranDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Dorothea BoekenUK Dementia Research Institute at the University of Cambridge, Cambridge, UK.ORCID 0009-0008-8443-4469
Yu ChenDepartment of Bioengineering, Northeastern University, Boston, MA, USA.
Joshua E ChunDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Anne WiedmerDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Victoria DeroslaDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Mariana B M S MartinsDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Forest A BrooksDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Georg MeislUK Dementia Research Institute at the University of Cambridge, Cambridge, UK.ORCID 0000-0002-6562-7715
Matthew CottonYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.
Durga G ArumuganainarBioinformatics Program, Northeastern University, Boston, MA, USA.
Theresa ConnorsDepartment of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Alexandra MelloniDepartment of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Mathew FroschDepartment of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Derek OakleyDepartment of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Lee MakowskiDepartment of Bioengineering, Northeastern University, Boston, MA, USA.ORCID 0000-0003-0202-9264
Meni WanunuDepartment of Bioengineering, Northeastern University, Boston, MA, USA.
David KlenermanUK Dementia Research Institute at the University of Cambridge, Cambridge, UK.ORCID 0000-0001-7116-6954
Bradley T HymanDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-7959-9401

Funding

Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Christine S Ritchie · 2019 to 2026
$36.5M
Fibrillar polymorphs in human brain tissueRF1AG079946 · NIA · NORTHEASTERN UNIVERSITY · PI MAKOWSKI, LEE · 2023 to 2023
$2.1M
NIA NIH HHS P30 AG062421NIA NIH HHS RF1 AG079946
6 · The paper itself

Abstract

The accumulation of hyperphosphorylated tau aggregates is a hallmark of Alzheimer's disease (AD). In addition to long-recognized tau deposits in neurofibrillary tangles, recent studies suggest that diffusible, aqueous soluble (High Molecular Weight, or HMW) species are also bioactive, i.e., able to seed templated misfolding. The characteristics of the diffusible misfolded proteins are largely unknown, and their relationship to classical fibrillar structures is unclear. Using sequential size exclusion and anion exchange chromatography, we fractionated the HMW tau population and identified multiple subspecies varying in retention properties. The subspecies that elute early from the size column, and are retained on the anion exchange column are seed competent, whereas the other soluble fractions are not. Biophysical analyses using super resolution, atomic force, and immunogold electron microscopy confirmed that the size and conformation of both bioactive and non-bioactive tau oligomers are similar, with dimers, trimers, and tetramers predominating. The presence of surface phosphorylations, as detected by recently developed single molecule array (SIMOA) analyses, correlates with seeding capacity. Single bioactive tau oligomers at fMol concentrations can induce seeding and templated misfolding in a reporter cell. The bioactive species can alternatively support aggregation of a truncated repeat domain tau construct into thioflavin T positive fibrils in a real-time quacking-induced conversion (RT-QuIC) assay, whereas full length recombinant tau yields oligomers. These findings provide structural insights into bioactive oligomeric tau species, emphasize the small concentrations necessary for bioactivity, and highlight the possibility that, under different conditions, they can seed either oligomeric or fibrillar structures.

Indexed as

Alzheimer’s diseasebioactive specieshuman brain tissuenon-bioactive speciesoligomerphosphorylationsprion-like mechanismRT-QuICseedsuper resolution microscopyTau

Identifiers

PMID41040357
PMCPMC12485776

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.